Neoadjuvant Combination Immunotherapy for Stage III Melanoma
Clinical trial NCT03842943 · RECRUITING
Trial details
- NCT number
- NCT03842943
- Sponsor
- University of Louisville
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-03
- Primary completion
- 2026-06-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.